Carroll Financial Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,750
Closed -$3K 1281
2016
Q1
$3K Hold
1,750
﹤0.01% 1021
2015
Q4
$4K Buy
+1,750
New +$5.19K ﹤0.01% 935

Carroll Financial Associates's SZYM Position: Q2 2016 in Review

Carroll Financial Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 1,750 shares — an estimated $3K sold.

Carroll Financial Associates first reported a position in SZYM in Q4 2015 and held it in 2 quarters. The position peaked at $4K in Q4 2015. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Carroll Financial Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Carroll Financial Associates sold 1,750 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $3K.
  • Carroll Financial Associates first reported a position in SOLAZYME INC COM STK (DE) in Q4 2015 and held it in 2 quarters.
  • Carroll Financial Associates's SOLAZYME INC COM STK (DE) position peaked at $4K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Carroll Financial Associates's 13F filing for Q2 2016, filed 18 Jul 2016.